Enfusion, Inc (ENFN) Files For Up to $100M IPO

Enfusion, Inc (NYSE: ENFN) files for up to $100,000,000 IPO.

The company describes itself as: "Enfusion is a global, high-growth software-as-a-service, or SaaS, provider focused on transforming the investment management industry. Our solution is designed to eliminate technology and information barriers, empowering investment managers to confidently make and execute better-informed investment decisions in real time. We simplify investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. This allows stakeholders throughout the entire client organization to interact more effectively with one another across the investment management lifecycle."

Morgan Stanley and Goldman Sachs & Co. LLC will serve as lead underwriters.

You May Also Be Interested In